ArticleBone marrow transplantation2018

Allogeneic stem cell transplantation for non-de novo AML or advanced myelodysplastic syndromes: influence of GvHD and donor lymphocyte infusions on long-term outcome.

P G Hemmati et al.PubMed ↗Publisher ↗

No numbers read from the abstract.